Management of Significant Cell Count in Pleural Effusion

Initial Diagnostic Approach

The management approach depends critically on the predominant cell type: lymphocyte-predominant effusions require exclusion of tuberculosis and malignancy, while neutrophil-predominant effusions indicate parapneumonic effusion/empyema requiring immediate drainage and antibiotics, as recommended by the American Thoracic Society 1, 2
Perform diagnostic thoracentesis with ultrasound guidance to minimize complications and send fluid for nucleated cell count with differential, protein, LDH, glucose, pH, and cytology, according to the American College of Chest Physicians 2, 3

Lymphocyte predominance (>50% lymphocytes) strongly suggests tuberculosis or malignancy as the primary differential diagnoses, with a high level of evidence from the American Journal of Respiratory and Critical Care Medicine 1, 2
Malignant effusions typically show lymphocytes or other mononuclear cells predominating, though >25% eosinophils is unusual but does not exclude malignancy, as noted by the American Thoracic Society 5, 2
Tuberculosis and malignancy must be excluded in the presence of pleural lymphocytosis through additional testing including adenosine deaminase, gamma-interferon levels, and cytology, as recommended by the American College of Chest Physicians 1

All patients with parapneumonic effusion/empyema must be hospitalized immediately and started on intravenous antibiotics covering Streptococcus pneumoniae at minimum, according to the Infectious Diseases Society of America 1
Insert a chest drain at the outset if significant pleural infection is present, with a low level of evidence from the American Thoracic Society 1
Use small-bore chest tubes (14F or smaller) to reduce complications, as recommended by the Society of Critical Care Medicine 4

Low pleural fluid pH (≤7.28) and glucose (<60 mg/dl) in malignant effusions indicate higher tumor burden in pleural space, higher initial cytologic diagnostic yield, and worse survival prognosis, with a moderate level of evidence from the American Journal of Respiratory and Critical Care Medicine 2
However, pH has insufficient predictive accuracy alone for selecting patients for pleurodesis and should be used in conjunction with performance status, tumor type, and response to therapeutic thoracentesis, as noted by the American College of Chest Physicians 2

Do not remove >1.5L during single thoracentesis, due to the risk of re-expansion pulmonary edema, as warned by the American College of Chest Physicians 4
Do not perform intercostal tube drainage without pleurodesis for malignant effusions, due to the high recurrence rate with no advantage over simple aspiration, according to the Society of Critical Care Medicine 4
Biochemical analysis of pleural fluid is unnecessary in uncomplicated parapneumonic effusions/empyema beyond the essential tests listed above, as stated by the American Thoracic Society 1